Author

Jorn Brink

Leiden UniversityPrimary ORCID profile (0000-0002-5782-2617 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Jorn BrinkiD1 paper · Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Anne‐Grete MärtsoniD· 1 shared Dirk-Jan van den Berg· 1 shared J. G. Coen van HasseltiD· 1 shared Lalitya M. SudarsonoiD· 1 shared Suzanne A M Wenker· 1 shared Xuanlin LiuiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Anne‐Grete MärtsonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A Novel Hollow Fiber Infection Model (HFIM) for Antiviral PK/PD studies of CMV infection.

Lalitya M. Sudarsono, Suzanne A M Wenker, Xuanlin Liu, Jorn Brink, Dirk-Jan van den Berg, J. G. Coen van Hasselt, Anne‐Grete Märtson

This paper introduces a novel hollow fiber infection model (HFIM) for PK/PD studies of ganciclovir in CMV infection, enabling reliable drug exposure and viral dynamics analysis.

Antimicrobial Agents and Chemotherapy · Jun 18, 2026Peer-reviewedPharmacology & Toxicology